BGA 006
Alternative Names: BGA-006Latest Information Update: 11 Feb 2022
At a glance
- Originator BIOGENERA
- Class Antineoplastics; Oligonucleotides
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; Genetic transcription inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 04 Feb 2022 Early research in Unspecified in Italy (Parenteral) (Biogenera pipeline, February 2022)